Affordable Access

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

Authors
Type
Published Article
Journal
Oncology reports
Publication Date
Volume
16
Issue
2
Pages
393–398
Identifiers
PMID: 16820921
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments